Answers are grounded in this paper and cite their sources.
Melasma is a common dermatologic condition affecting all skin types. Increasing rates of melasma warrant identification of a reliable topical treatment. In recent years, off-label tranexamic acid (TA) has emerged as a potential treatment of melasma. Although the mechanism of action remains unclear, it is thought that TA inhibits melanin synthesis by blocking the interaction between melanocytes and keratinocytes while reversing the abnormal dermal changes associated with melasma. Our study assessed the efficacy of TA solution 5% for the treatment of melasma in patients with darker skin types.
No takes yet. Share an insight, caveat, or question.
Nazia Akhtar (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: